超声引导泡沫硬化疗法治疗慢性静脉性溃疡疗效可喜
研究纳入2018年1月至2020年12月共279例(336条腿)CEAP C6期慢性静脉性溃疡患者,采用聚多卡醇泡沫硬化治疗轴向静脉反流,52周时156例(56%)完全愈合、89例(32%)溃疡面积缩小>50%;愈合难度与溃疡病程、溃疡大小、淋巴水肿、踝背屈受限及年龄≥65岁显著相关。
要点
- 279例CEAP C6期患者中156例(56%)52周完全愈合,89例(32%)溃疡面积缩小>50%。
- 溃疡病程至治疗开始时间(P<.01)、溃疡大小(P=.01)、淋巴水肿(P=.006)、踝背屈受限(P=.01)、年龄≥65岁(P=.003)与愈合困难显著相关。
- 平均静脉临床严重程度评分为18.7分的患者预后优于22.5分者(18.7 vs 22.5;P<.001)。
核心结论
- 大多数接受泡沫硬化疗法治疗的慢性静脉性溃疡(CEAP 6期)患者在52周内实现愈合或显著改善。
- 愈合高度受治疗前病程、溃疡大小、踝背屈受限和/或淋巴水肿以及压力治疗使用的影响。
研究设计与样本
- 2018年1月至2020年12月纳入279例(336条腿)首次就诊时CEAP分期为6期的患者,随访52周。
- 采用聚多卡醇(Aethoxysklerol)泡沫治疗大隐静脉及属支的轴向静脉反流。
- 使用Kaplan-Meier统计和Cox回归分析协变量的影响。
主要发现
- 279例患者平均年龄55岁。
- 52周时156例(56%)完全愈合,89例(32%)溃疡面积缩小>50%。
- 溃疡大小、严重程度、淋巴水肿和踝背屈受限与愈合困难显著相关。
- 溃疡进展至开始治疗的时间(P<.01)、溃疡大小(P=.01)、淋巴水肿(P=.006)、踝背屈受限(P=.01)和年龄≥65岁(P=.003)与愈合困难显著相关。
- 平均静脉临床严重程度评分为18.7分的患者预后优于22.5分者(18.7 vs 22.5;P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in wound care, the dressing and management of chronic ulcers on lower limbs remains unsatisfactory. The simplicity, cost effectiveness, and diverse application possibilities of ultrasound-guided foam sclerotherapy make it an attractive and effective approach to treat patients with no access to or contraindications to more invasive methods. We sought to evaluate the healing rate of chronic venous ulcers (Clinical, Etiological, Anatomical, Pathophysiological [CEAP] C6) in patients treated with ultrasound guided foam sclerotherapy. METHODS: From January 2018 to December 2020, 279 patients (336 legs) classified at the first consultation as stage 6 for CEAP disease were followed during treatment of axial venous reflux in saphenous and tributary veins with polidocanol (Aethosxysklerol) foam and evaluated at 52 weeks for complete healing rates or ≥50% ulcer size reduction, using Kaplan-Meier statistics and Cox regression to study the influence of covariates. RESULTS: The average age of the 279 patients was 55 years. Of these, 156 (56%) showed complete healing in 52 weeks and 89 (32%) achieved a wound area reduction of >50%. Ulcer size, severity, lymphedema, and reduced dorsiflexion of the ankle were significantly associated with healing difficulty. Time of ulcer progression up to beginning of treatment (P < .01), ulcer size (P = .01), lymphedema (P = .006), reduced dorsiflexion of the ankle (P = .01), and age ≥65 years (P = .003) were significantly associated with difficulty in healing. Patients with a mean Venous Clinical Severity Score of 18.7 had a better prognosis (18.7 vs 22.5; P < .001). CONCLUSIONS: Most patients with chronic venous ulcers (CEAP 6) treated with foam sclerotherapy achieved healing or significant improvement within 52 weeks. Healing was highly influenced by time until treatment, ulcer size, reduced dorsiflexion of the ankle and/or lymphedema presence, and the use of compression therapy.
引用
- Bacelar ACC, Netto EM, Barreto N, et al. Promising results of ultrasound guided foam sclerotherapy for treating chronic venous ulcers. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 39890082. doi:10.1016/j.jvsv.2025.102198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。